educating healthcare professionals and advancing public policy for the Alpha-1 Community.” 
|
CSL Completes Acquisition of Aventis Behring
From the www.zlbbehring.com web site:
At ZLB Behring, we understand the needs of the patients that rely on our products. For individuals with hemophilia, even minor bleeding can become life-threatening. Victims of severe trauma and burns struggle with loss of plasma. While other patients face wounds that won't heal or immune systems too weak to fight infection.
As a company with a long combined history of creating a stable supply of life-saving therapies, ZLB Behring will continue this leadership tradition by providing plasma and recombinant therapies that make the difference for millions of patients and those in life-and-death situations.
"The creation of ZLB Behring, as an important part of the CSL Group is a watershed for us and for the patients that depend on our products. Combining ZLB Bioplasma and Aventis Behring creates an organization that is focused on plasma and recombinant therapeutic products, resulting in even greater stability in supply over the long-term." says Peter Turner, President of ZLB Behring. Peter is based in King of Prussia, Pennsylvania, USA.
Our existing portfolio of high quality products, services and distribution methods will continue as usual for the time being. We've taken many measures to ensure that this is a seamless transition for you. As we roll out improvements and changes to our product lines and customer service, we will be sure to inform you in an immediate and timely manner.
We are excited about the future of this company and the benefits that this combination will provide to patients and customers alike. ZLB Behring has the global scale to lead this industry, with talented people, efficient manufacturing and plasma collection capabilities and leading-edge research and development endeavors.
Telephone: 540-948-6777 or 1-866-FOR-A1AA (1-866-367-2122) Fax # 540-948-6763
Copyright © 2005 Alpha-1 Advocacy Alliance, All Rights Reserved
Home | Disclaimer | Privacy Policy